(Q41639389)

5 October 2017

1 reference

title

Antiarrhythmic drug therapy in the management of atrial fibrillation (English)

1 reference

5 October 2017

Ganz LI

1

1 reference

5 October 2017

Antman EM

series ordinal

2

1 reference

5 October 2017

publication date

1 October 1997

1 reference

Journal of Cardiovascular Electrophysiology

5 October 2017

published in

1 reference

5 October 2017

volume

8

1 reference

5 October 2017

issue

10

1 reference

5 October 2017

page(s)

1175-1189

1 reference

Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (the sotalol-digoxin-quinidine trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Proarrhythmia in patients treated for atrial fibrillation or flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Adverse reactions to procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. The Propafenone Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Atrial flutter in patients treated for atrial fibrillation with propafenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Amiodarone: reevaluation of an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Low-dose amiodarone for atrial fibrillation: time for a prospective study?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Proarrhythmia: definition, risk factors, causes, treatment, and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Amiodarone and torsades de pointes in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8167.1997.TB01005.X

10.1111/J.1540-8167.1997.TB01005.X

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference